Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell CarcinomaSuzanne C van Es, Adrienne H Brouwers, Shekar V K Mahesh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2017
Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation TherapyLinda W Sommers, Roel J H M Steenbakkers, Henk P Bijl, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|February 14, 2025
Comparison of White Light With Narrow Band Imaging Using Flexible Laryngoscopy for the Detection of Local Recurrences After (Chemo)Radiation for Pharyngeal or Laryngeal Cancer: A Randomised Controlled TrialConstanze Scholman, Jeroen M Westra, Manon A Zwakenberg, et al.
JACC. Advances|November 25, 2024
Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective StudyPieter F van den Berg, Valentina Bracun, Michel Noordman, et al.
Cancer Research|April 13, 2013
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptakeMarlous Arjaans, Thijs H Oude Munnink, Sjoukje F Oosting, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2014
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategiesVikram R Bollineni, Michel J B Koole, Jan Pruim, et al.
Theranostics|February 12, 2020
Molecular imaging biomarkers for immune checkpoint inhibitor therapyPim P van de Donk, Laura Kist de Ruijter, Marjolijn N Lub-de Hooge, et al.
American Journal of Otolaryngology|April 19, 2024
Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastasesJeroen E van Schaik, Bert van der Vegt, Lorian Slagter-Menkema, et al.
Oral Oncology|July 18, 2016
A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancerSjoukje F Oosting, Tom W W Chen, Shao H Huang, et al.
Pageof 8